Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1447 |
|---|---|
| Identifier | NCT05028946 |
| Trial Title | A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Foralumab |
Participant Information
| Sponsor | Tiziana Life Sciences LTD |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2022-05-01 |
|---|---|
| Primary Completion Date | 2023-07-07 |
| Completion Date | 2023-11-07 |